Abstract The insulin receptor (IR) is expressed ubiquitously in various tissues, where insulin exerts various biological effects on the target cells, such as cellular metabolic changes, cell proliferation and differentiation. Therefore, mimicry of insulin signaling would be a promising strategy to realize artificial control of such cellular fates. In this study, we constructed an antibody/insulin receptor chimera that enables to utilize any antigen as the ligand in principle. We constructed chimeric receptors consisting of antifluorescein single chain Fv (scFv), the extracellular D2 domain of erythropoietin receptor and the transmembrane/intracellular domains of IR (scFv-IR; S-IR). The function of S-IR was evaluated in terms of growth signal transduction in murine pro-B Ba/F3 cells and murine fibroblast NIH/3T3 cells. S-IR exerted IL-3-independent cell growth in Ba/F3 cells, while NIH/ 3T3 cells expressing S-IR acquired growth advantage over parental NIH/3T3 cells in a low-serum condition. S-IR induced phosphorylation of S-IR itself and key signaling molecules downstream of IR. Although antigen-independent activation was significantly observed, S-IR enabled specific amplification of the gene-transduced cells.
Introduction
Insulin is a peptide hormone that is secreted by pancreatic b cells, and plays important roles in vivo by binding to an insulin receptor (IR). The IR is a receptor tyrosine kinase which is expressed in almost all mammalian cell types. The gene of the IR encodes a proreceptor that undergoes several processing steps. As a co-translational event, two proreceptor chains form an interchain disulfide dimer. Subsequently, the dimeric proreceptor is cleaved into a and b subunits. Thus, the mature IR is an a 2 b 2 disulfide-linked heterotetramer (Gorden et al. 1989) . The a subunit is located entirely at the extracellular face of the plasma membrane and contains the insulin recognition site. In contrast, the b subunit is a membrane protein that consists of several functional domains; an extracellular domain that links to the a subunit through a disulfide bond, a transmembrane domain, and an intracellular domain that contains an ATP-binding region, a catalytic site and several tyrosine motifs. If a ligand binds to the a subunit, conformational change of the receptor complex makes the b subunits transphosphorylate each other, which activates the catalytic domain and downstream signal transduction (Goren et al. 1987 ).
The IR is expressed ubiquitously in various tissues including adipose tissue, muscle, liver and pancreas, where insulin exerts various biological effects on the target cells, such as glucose uptake in muscle cells and adipocyte differentiation (Belfiore et al. 2009 ). Therefore, mimicry of insulin signaling would be a promising strategy to realize artificial control of such cellular fates. To this end, several chimeric receptors using the IR signaling domain have been generated (Chaika et al. 1997; Yang et al. 1998) . The fusion proteins composed of FK-binding protein 12 (FKBP12) or the extracellular domain of colony-stimulating factor (CSF)-1 receptor and the intracellular domain of IR transduced a differentiation signal in response to their corresponding ligand, FK1012 or CSF-1, respectively. However, FKbinding protein and CSF-1 receptor are expressed endogenously in various types of cells. Therefore, it is of great advantage if we could achieve the regulation of insulin signaling by desired molecules.
To achieve this, we have developed a series of antibody/receptor chimeras that in principle enable to utilize any antigen as the ligand Kawahara et al. 2010) . For example, chimeric receptors consisting of anti-fluorescein (FL) single chain Fv (scFv), the extracellular D2 domain of erythropoietin receptor (EpoR) and the transmembrane/intracellular domains of EpoR (Liu et al. 2009 ), gp130 (Kawahara et al. 2004a ), interleukin-2 receptor (IL-2R) (Sogo et al. 2009 ) or c-Mpl (Kawahara et al. 2011 ) transduced a growth signal in several hematopoietic cell lines and primary cells. Moreover, the chimeric receptors harboring the intracellular domain of the epidermal growth factor receptor (EGFR) (Tanaka et al. 2009 ), c-Fms (Tanaka et al. 2009 ) or c-Kit (Kaneko et al. 2012 ) that belong to the RTK family as well as IR, proved to be functional in both hematopoietic and fibroblast cell lines.
To prove that this approach could be extended to IR, we constructed a chimeric receptor consisting of anti-FL scFv, the EpoR D2 domain and the transmembrane/intracellular domains of IR, named S-IR. We investigated whether the S-IR chimera could transduce a growth signal in Ba/F3 cells and NIH/3T3 cells.
Materials and methods

Vector construction
A chimeric receptor consisting of an FL scFv, the extracellular D2 domain of EpoR, and the transmembrane (TM)/intracellular (IC) domains of human IR was constructed. Two fragments, IR 1st and IR 2nd, were amplified from pHIR/p12-1 (purchased from American Type Culture Collection, Manassas, VA, USA) with four primers (IR 1st forward: 5 0 -GG GAAGCTTGATATCATTATCATCGGCCCCCTC-3 0 , IR 1st reverse: 5 0 -GGGCTGCAGCCATCTGAATC ATCTCT-3 0 , IR 2nd forward: 5 0 -GGGCTCGAGCTG CAGAGATTGCTGACGGG-3 0 , and IR 2nd reverse: 5 0 -GGGATCGATGCCCCCGGAAGGATTGGACCG AGGCA-3 0 ). The IR 1st was digested with HindIII and PstI, and the fragment was inserted into HindIII-and PstI-digested pBluescriptII SK(-) (Stratagene, La Jolla, CA, USA) to obtain pBS-IR1. The IR 2nd was digested with PstI and ClaI, and ligated into PstI-and ClaI-digested pBS-myc (Sogo et al. 2008 ) to yield pBS-IR2-myc. After sequencing of IR fragments, pBS-IR2-myc was digested with PstI and BamHI, and inserted into PstI-and BamHI-digested pBS-IR1, to produce pBS-IR-myc. pBS-IR-myc was digested with EcoRV and BamHI, and ligated into EcoRV-and BamHI-digested pBS-Eb-IG (Sogo et al. 2008 ) to create pBS-E-IR-myc-IG. pBS-E-IR-myc-IG was digested with BspEI and BamHI, and inserted into BspEI-and BamHI-digested pMK-Sb-IG (Sogo et al. 2009 ), which is a bicistronic retroviral plasmid encoding anti-FL scFv-IL-2Rb chimera and enhanced green fluorescent protein (EGFP) genes, to make pMK-S-IR-myc-IG. This final product encodes the myc-tagged S-IR gene upstream of an internal ribosomal entry site (IRES)-EGFP cassette.
To construct a mock vector, pMK-S-EGFR-IG (Tanaka et al. 2009 ) was digested with EcoRI and BamHI to remove the sequence encoding the S-EGFR chimera, followed by blunting and self-ligation to yield pMK-IG.
Cell culture
A murine IL-3 dependent pro-B cell line, Ba/F3 (RCB0805, RIKEN Cell Bank, Tsukuba, Japan), was cultured in RPMI1640 medium (Nissui Pharmaceutical, Tokyo, Japan) supplemented with 10 % FBS (Biowest, Nuaillé, France) and 2 ng/ml IL-3 (R&D systems, Cambridge, MA, USA). A mouse fibroblast NIH/3T3 was cultured in Dulbecco's modified Eagle's Medium (DMEM) (Nissui Pharmaceutical) supplemented with 10 % FBS. A retroviral packaging cell line, Plat-E (Morita et al. 2000) , was cultured in DMEM supplemented with 10 % FBS, 1 lg/ml puromycin (Sigma, St Louis, MO, USA) and 10 lg/ml blasticidin (Kaken Pharmaceutical, Tokyo, Japan).
Retroviral transduction
Plat-E cells were plated into a 60 mm diameter dish at 5 9 10 5 cells/ml in 4 ml of a culture medium, and cultured for 20 h. An aliquot of 9 ll Fugene6 (Roche Diagnostics, Basel, Switzerland) was diluted with 100 ll of serum-free DMEM and added to 1 lg of the retroviral plasmid solubilized in 6 ll of sterile water. After 15 min incubation at room temperature, the plasmid/Fugene6 mixture was added to the Plat-E cells. After 24 h incubation, the culture medium was refreshed, followed by additional incubation for 24 h. After the supernatant was centrifuged at 1,000g for 5 min at 20°C, Ba/F3 or NIH/3T3 cells (1 9 10 5 ) were transduced with 500 ll of the viral supernatant in the presence of 10 lg/ml polybrene (Sigma) and 4 ng/ ml IL-3 in a 24-well plate. After incubation for 5 h, 500 ll of a fresh culture medium was added to reduce the toxicity of polybrene. The transduction efficiency was estimated from the percentage of EGFP-positive cells which was measured by flow cytometry on day 3 or 4 after retroviral transduction.
Growth selection
As for Ba/F3, the cells after retroviral transduction (2 9 10 5 ) were washed once, and seeded into 24-well plates. Selection was performed in the medium without any additional factors or with 5 lg/ml BSA-FL (Sigma). After selection, the cells were analyzed by flow cytometry to measure the ratio of transduced cells. As for NIH/3T3, the cells after retroviral transduction (5 9 10 3 ) were seeded into 24-well plates. Selection was performed in the DMEM supplemented with 3 % FBS and without BSA-FL. After cells became sub-confluent, cells were further subcultured, and the remainder of the cells was subjected to flow cytometry to examine the ratio of transduced cells. This subculture/flow cytometry cycle was repeated during approximately 1-month selection.
Flow cytometry
The cells were washed once with PBS and resuspended in PBS. Green fluorescence intensity was measured by a FACSCalibur flow cytometer (BectonDickinson, Lexington, KY, USA) at 488 nm excitation and fluorescence detection at 530 ± 15 nm.
Western blotting
The cells (1 9 10 6 ) were washed with PBS, lysed with 100 ll of lysis buffer (20 mM HEPES (pH 7.5), 150 mM NaCl, 10 % glycerol, 1 % Triton X-100, 1.5 mM MgCl 2 , 1 mM EGTA, 10 lg/ml aprotinin, 10 lg/ml leupeptin) and incubated on ice for 10 min. After centrifugation at 21,500g for 10 min, the supernatant was mixed with Laemmli's sample buffer and boiled. The lysate was resolved by SDS-PAGE and transferred to a nitrocellulose membrane (GE Healthcare, Buckinghamshire, UK). The membrane was blocked with 5 % skimmed milk (Wako Pure Chemical Industries, Osaka, Japan) for the detection of myc tag, Akt, ERK and b-tubulin or with Blocking One-P (Nacalai Tesque, Kyoto, Japan) for the detection of phosphorylated Akt and ERK. The blot was probed with a 1:1,000 diluted primary rabbit antibody, followed by 1:1,000 diluted HRP-conjugated anti-rabbit IgG (Biosource, Camarillo, CA, USA), and the detection was performed using Chemi-Lumi One (Nacalai Tesque, Kyoto, Japan) or ECL Prime Western Blotting Detection Reagent (GE Healthcare, Piscataway, NJ, USA). Primary rabbit antibodies used were: anti-c-myc tag (BETHYL, Montgomery, TX, USA), anti-ERK1 (Santa Cruz Biotechnology, Santa Cruz, CA, USA), anti-Akt (Cell Signaling Technology, Danvers, MA, USA), anti-b-tubulin (Santa Cruz Biotechnology), antiphospho IR (Tyr1162/1163) (Santa Cruz Biotechnology), anti-phospho ERK (Santa Cruz Biotechnology) and anti-phospho Akt (Cell Signaling Technology).
Stimulation
As for Ba/F3 variants, the cells were washed with PBS, and starved in a depletion medium containing neither IL-3 nor BSA-FL for 12 h. Then, the cells were stimulated with 1 ng/ml IL-3 or 1 lg/ml BSA-FL for 15 min at 37°C, followed by addition of ice-cold 1 mM Na 3 VO 4 (Sigma) in PBS. Cell lysate was prepared as described in western blotting.
As for NIH/3T3 variants, the cells were incubated in DMEM supplemented with 3 % FBS for 3 days. Then the cells were starved in the depletion medium (DMEM supplemented with 0.5 % FBS) for 6 h.
The cells were stimulated with 3 % FBS or 5 lg/ml BSA-FL for 20 min, followed by addition of ice-cold 1 mM Na 3 VO 4 in PBS. Cell lysate was prepared as described in western blotting.
Proliferation assay
Cells were washed and seeded in 96-well plates containing various BSA-FL concentrations. Initial cell concentration was adjusted to 4 9 10 3 and 1 9 10 4 cells/ml for Ba/F3 and NIH/3T3 variants, respectively. After incubation for several days, the cell number was determined using the Cell Counting Kit8 (Dojindo, Kumamoto, Japan) and flow cytometry for Ba/F3 and NIH/3T3 variants, respectively.
Results
Specific expansion of gene-transduced cells with S-IR chimera
To examine whether the antibody/insulin receptor chimera (S-IR) could achieve selective expansion of transduced cells, we constructed a bicistronic retroviral plasmid named pMK-S-IR-myc-IG, which encodes S-IR and a model/marker protein EGFP (Fig. 1) . Firstly, IL-3-dependent pro-B Ba/F3 cells, in which several receptor tyrosine kinases are functional (Kobayashi et al. 2005; Ohashi et al. 1994a, b) , were retrovirally transduced with MK-S-IR-myc-IG, resulting in Ba/S-IR cells. Flow cytometric analysis revealed that the percentage of EGFP-positive cells of Ba/S-IR was 0.08 % (data not shown). These cells were washed to remove IL-3, and cultured in medium with or without BSA-FL as an antigen to test whether the antigen could amplify genetically modified cells. Consequently, cells in both media survived and proliferated, leading to a percentage of EGFP-positive cells of almost 100 % (Fig. 2a) . These results indicate that S-IR is constitutively active in Ba/F3 cells. To examine the BSA-FL dependency of Ba/S-IR in more detail, the Ba/S-IR cells selected with BSA-FL were cultured in various BSA-FL concentrations, and viable cell concentration was measured. As expected, no significant difference was observed among all BSA-FL concentrations tested (Fig. 2b) . These results indicate that the S-IR chimera transduces a growth signal in an antigen-independent manner in Ba/F3 cells.
To check the signaling properties of S-IR also in a different cell line, NIH/3T3 cells were retrovirally (Fig. 3a, Day 0) . The cells were subjected to growth selection, in which the cells were periodically passaged in a medium containing only a low concentration of serum (3 % FBS) without BSA-FL. As shown in the flow cytometric analysis at every passage, the percentage of EGFP-positive cells increased up to 60 ± 10 % after 31-day culture (Fig. 3a) . In contrast, mock vector-transduced cells showed 52.8 % EGFP-positive on day 0, and the ratio gradually decreased until day 17 (42.6 ± 4.9 %; data not shown). These results indicate that the NIH/S-IR cells acquired a growth advantage over parental NIH/ 3T3 cells even without BSA-FL when cultured in the low-serum condition.
To examine the BSA-FL dependency of NIH/S-IR cells, the cells after selection were subjected to a growth assay. As expected, NIH/S-IR cells grew independent of BSA-FL concentrations tested (Fig. 3b) . These results suggest that S-IR chimera is constitutively active and promotes cell growth in NIH/ 3T3 cells as well.
Activation of S-IR and downstream signal transducers
Insulin leads to phosphorylation of IR and downstream signaling molecules. IR phosphorylates insulin receptor substrate (IRS) that activates two major signaling pathways: the phosphatidylinositol 3-kinase (PI3K)-Akt pathway, which plays important roles in the metabolic actions of insulin, and the Ras-mitogenactivated protein kinase (MAPK) pathway, which cooperates with the PI3K-Akt pathway to control cell growth and differentiation (Taniguchi et al. 2006) . To characterize the signaling properties of S-IR, we examined phosphorylation of S-IR, Akt and ERK with or without BSA-FL stimulation. The cells were starved in a depletion medium, and stimulated with BSA-FL, IL-3 or FBS, followed by western blot analyses using antibodies against phosphorylated signaling molecules. Consequently, phosphorylation of S-IR, Akt and ERK was clearly observed in the Ba/ S-IR cells (Fig. 4) . These signaling molecules were constitutively phosphorylated even without BSA-FL, which is consistent with the unregulated cell growth of Ba/S-IR (Fig. 2b) . In the NIH/S-IR cells, S-IR and Akt were constitutively phosphorylated in a BSA-FLindependent manner, although phosphorylation levels of ERK were similar to those in the parental NIH/3T3 cells (Fig. 5) . These results suggest that S-IR can activate key signaling molecules that are activated by wild-type IR, although S-IR is constitutively active.
Discussion
In this study, we constructed an antibody/insulin receptor chimera, S-IR, to mimic IR signaling. The function of S-IR was evaluated in terms of growth signal transduction in murine pro-B Ba/F3 cells and murine fibroblast NIH/3T3 cells. S-IR exerted IL-3-independent cell growth in Ba/F3 cells, while NIH/ 3T3 cells expressing S-IR acquired growth advantage over parental NIH/3T3 cells in a low-serum condition. S-IR induced phosphorylation of S-IR itself and key signaling molecules downstream of IR. Consequently, the gene-transduced cells were successfully amplified by signaling through S-IR. Although we have previously constructed a series of antibody/receptor chimeras (Kaneko et al. 2012; Kawahara et al. 2004a Kawahara et al. , 2011 Liu et al. 2009; Sogo et al. 2009; Tanaka et al. 2009 ), this is the first report utilizing IR as a signaling domain.
Although S-IR was demonstrated to transduce a growth signal, antigen-independent activation was significantly observed. It was reported that a subunit of wild-type IR, which consists of the extracellular region of the receptor complex, prevents auto- (Goren et al. 1987; Taniguchi et al. 2006) . Since the S-IR chimera bears a completely different domain organization (scFv-EpoR D2 domain) compared to wild-type IR (a 2 b 2 disulfide-linked hetero-tetramer) in the extracellular domain, mimicry of the switched-off state may be challenging. In previous studies, Chaika et al. constructed the CSF-1R/IR chimera that can signal ligand-dependently (Chaika et al. 1997) . In this case, the chimera contains the extracellular domain of another wild-type receptor, CSF-1R, which may keep the unliganded chimera in a switched-off state. In the case of Yang et al. there is background activation of downstream signaling molecules, but the activation levels with a ligand were much higher than those without a ligand (Yang et al. 1998) . In this case, the chimeric receptor lacks the transmembrane domain which significantly contributes to interchain interaction of receptor chains (Dawson et al. 2002) . These previous reports are consistent with our notion that the conformation and interchain interaction of the receptor complex are key determinants for the signaling properties of cytokine receptors (Kawahara et al. 2004b; Liu et al. 2008 ). To develop a strictly antigendependent S-IR variant, one may modify the domain organization of the extracellular domain, and/or introduce mutations in the transmembrane domain to diminish the interchain interaction. In our previous study, the antibody/RTK chimeras and antibody/type I cytokine receptor chimeras, which have the same extracellular domain structure as S-IR, transduced a growth signal in an antigen-dependent manner in Ba/F3 cells. In this study, however, S-IR transduced an antigen-independent cell growth in Ba/F3 and NIH/ 3T3 cells. This may be due to the fact that IR has a more complex structure in the extracellular domain than other RTKs. While a quite recent report finally revealed the crystal structure of the ligand-recognition domain, the ligand-guided switching mechanism remains to be determined (McKern et al. 2006; Menting et al. 2013) . It is interesting that only IR and insulin-like growth factor-1 receptor (IGF-1R) adopt such complex structures in the extracellular domain for regulating the signaling (Ullrich et al. 1986 ). Previously, it was reported that IR and IGF-1R can form an IR/IGF-1R hybrid receptor (HR) which is activated by IGF-1/2 (Soos et al. 1990 (Soos et al. , 1993 . Of note, IGF-1/2 induces proliferation not only in normal cells but also in cancer cells such as breast and thyroid carcinomas, where HR formation has been confirmed Pandini et al. 1999) . However, the role of HRs is not entirely clarified due to the concurrent expression of homodimeric IR and IGF-1R. In our previous studies we succeeded the activation of chimeric receptors by using the homodimeric fluorescein tethered with a palindromic oligo-DNA linker (Kaneko et al. 2012; Kawahara et al. 2004a; Sogo et al. 2009) . If the cytoplasmic domains of IR and IGF-1R are, respectively, fused to scFvs with different specificities, the resultant chimeric receptors could exclusively form the heterodimer of scFv-IR and scFv-IGF-1R by heterodimeric antigens tethered with the oligo-DNA linker. If such constructs are successfully engineered with an antigen-dependent signaling property, the antibody/IR chimera may be applied to reveal the mechanism of HRs in development and cancer.
